0001140361-15-004856.txt : 20160308 0001140361-15-004856.hdr.sgml : 20160308 20150209164209 ACCESSION NUMBER: 0001140361-15-004856 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CollabRx, Inc. CENTRAL INDEX KEY: 0000931059 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 680370244 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 400 S. AUSTRALIAN AVENUE, SUITE 800 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 BUSINESS PHONE: 561-855-1626 MAIL ADDRESS: STREET 1: 400 S. AUSTRALIAN AVENUE, SUITE 800 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 FORMER COMPANY: FORMER CONFORMED NAME: CollabRx, Inc. DATE OF NAME CHANGE: 20120926 FORMER COMPANY: FORMER CONFORMED NAME: TEGAL CORP /DE/ DATE OF NAME CHANGE: 19950918 CORRESP 1 filename1.htm
AEGIS CAPITAL CORP.
810 Seventh Avenue, 18th Floor
New York, New York 10019

 
February 9, 2015

VIA EDGAR

United States Securities and Exchange Commission
Division of Corporation Finance
Mail Stop 4561100 F Street, N.E.
Washington, D.C. 20549

Attention: Gabriel Eckstein

Re: CollabRx, Inc.
Acceleration Request for Registration Statement on Form S-1, as amended
File No. 333-199477                            

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned, as the underwriter in connection with the offering pursuant to the above-captioned Registration Statement, hereby joins in the request of CollabRx, Inc. that the effective date of the above-captioned Registration Statement be accelerated to 5:00 p.m. Eastern Time on February 11, 2015, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.

 
Very truly yours,
     
 
AEGIS CAPITAL CORP.
     
 
By:
/s/ Anthony Monaco
   
Name: Anthony Monaco
   
Title: Chief of Compliance